Xponance, Inc. Abb Vie Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Xponance, Inc. holds 339,505 shares of ABBV stock, worth $61.5 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

339,505

Previous 332,586 2.08%

Holding current value

$61.5 Million

Previous $57 Million 17.53%

% of portfolio

0.66%

Previous 0.59%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $1.13 Million - $1.38 Million	6,919 Added 2.08%	339,505 $67 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $13.4 Million - $15.7 Million	-86,817 Reduced 20.7%	332,586 $57 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $1.09 Million - $1.24 Million	6,803 Added 1.65%	419,403 $76.4 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $963,337 - $1.08 Million	7,001 Added 1.73%	412,600 $63.9 Million
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $415,331 - $480,806	3,109 Added 0.77%	405,599 $60.5 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $658,044 - $818,893	4,966 Added 1.25%	402,490 $54.2 Million
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $1.16 Million - $1.33 Million	8,004 Added 2.05%	397,524 $63.4 Million
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $4.76 Million - $5.71 Million	34,407 Added 9.69%	389,520 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $3.42 Million - $3.92 Million	25,491 Added 7.73%	355,113 $47.7 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $1.18 Million - $1.51 Million	-8,602 Reduced 2.54%	329,622 $50.5 Million
Q1 2022 Apr 20, 2022	BUY	$131.98 - $163.75 $3.81 Million - $4.73 Million	28,895 Added 9.34%	338,224 $54.8 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $2.6 Million - $3.28 Million	24,162 Added 8.47%	309,329 $41.9 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $5.35 Million - $6.07 Million	-50,291 Reduced 14.99%	285,167 $30.8 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $1.09 Million - $1.22 Million	10,375 Added 3.19%	335,458 $37.8 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $13,912 - $15,316	-136 Reduced 0.04%	325,083 $35.2 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $141,018 - $190,389	1,752 Added 0.54%	325,219 $34.8 Million
Q3 2020 Oct 26, 2020	SELL	$85.91 - $100.83 $1.48 Million - $1.73 Million	-17,198 Reduced 5.05%	323,467 $28.3 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $25 Million - $33.4 Million	340,665 New	340,665 $33.4 Million

Others Institutions Holding ABBV

# of Institutions

3,854

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account